Status Update and Interim Results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2)

被引:53
作者
Halliday, Alison [1 ]
Bulbulia, Richard [1 ]
Gray, William [2 ]
Naughten, Ally [1 ]
den Hartog, Anne [1 ]
Delmestri, Antonella [1 ]
Wallis, Carol [1 ]
le Conte, Stephanie [1 ]
Macdonald, Sumaira [3 ]
Cras, P.
Hendriks, J. M. H.
Lauwers, P.
Hertoghs, M.
Van Schil, P.
De Jaegher, L.
Peeters, P.
Verbist, J.
Dendooven, D.
De Letter, J.
Vanhooren, G.
Astarci, P.
Capron, I.
Choghari, C.
Hammer, F.
Lacroix, V.
Peeters, A.
Verhelst, R.
Bosiers, M.
De Meester, K.
De Loose, K.
Van Buggenhout, E.
Vinck, E.
Geenens, M.
Hemelsoet, D.
Van Herzeele, I.
Vermassen, F.
De Koster, G.
Desiron, Q.
de Noordhout, A. Maertens
Malmendier, D.
Massoz, M.
Saad, G.
Cirelli, S.
Dormal, P.
Lerut, P.
Thues, E.
Coutts, S.
Demchuk, A.
Hill, M.
Hudon, M.
机构
[1] Univ Oxford, Oxford OX1 2JD, England
[2] Columbia Univ, New York, NY 10027 USA
[3] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England
关键词
Carotid artery stenosis; Stroke; Carotid artery stenting; Carotid endarterectomy; Randomized controlled trial; ENDARTERECTOMY;
D O I
10.1016/j.ejvs.2013.07.020
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: ACST-2 is currently the largest trial ever conducted to compare carotid artery stenting (CAS) with carotid endarterectomy (CEA) in patients with severe asymptomatic carotid stenosis requiring revascularization. Methods: Patients are entered into ACST-2 when revascularization is felt to be clearly indicated, when CEA and CAS are both possible, but where there is substantial uncertainty as to which is most appropriate. Trial surgeons and interventionalists are expected to use their usual techniques and CE-approved devices. We report baseline characteristics and blinded combined interim results for 30-day mortality and major morbidity for 986 patients in the ongoing trial up to September 2012. Results: A total of 986 patients (687 men, 299 women), mean age 68.7 years (SD +/- 8.1) were randomized equally to CEA or CAS. Most (96%) had ipsilateral stenosis of 70-99% (median 80%) with contralateral stenoses of 50-99% in 30% and contralateral occlusion in 8%. Patients were on appropriate medical treatment. For 691 patients undergoing intervention with at least 1-month follow-up and Rankin scoring at 6 months for any stroke, the overall serious cardiovascular event rate of periprocedural (within 30 days) disabling stroke, fatal myocardial infarction, and death at 30 days was 1.0%. Conclusions: Early ACST-2 results suggest contemporary carotid intervention for asymptomatic stenosis has a low risk of serious morbidity and mortality, on par with other recent trials. The trial continues to recruit, to monitor periprocedural events and all types of stroke, aiming to randomize up to 5,000 patients to determine any differential outcomes between interventions. Clinical trial: ISRCTN21144362. (C) 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:510 / 518
页数:9
相关论文
共 7 条
[1]  
Halliday A, 2004, LANCET, V363, P1491
[2]   10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial [J].
Halliday, Alison ;
Harrison, Michael ;
Hayter, Elizabeth ;
Kong, Xiangling ;
Mansfield, Averil ;
Marro, Joanna ;
Pan, Hongchao ;
Peto, Richard ;
Potter, John ;
Rahimi, Kazem ;
Rau, Angela ;
Robertson, Steven ;
Streifler, Jonathan ;
Thomas, Dafydd .
LANCET, 2010, 376 (9746) :1074-1084
[3]  
*NICE IPG 388, 2011, NICE INT PROC GUID I
[4]   Stent-protected angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy: SPACE2-a three-arm randomised-controlled clinical trial [J].
Reiff, T. ;
Stingele, R. ;
Eckstein, H. H. ;
Fraedrich, G. ;
Jansen, O. ;
Mudra, H. ;
Mansmann, U. ;
Hacke, W. ;
Ringleb, P. .
INTERNATIONAL JOURNAL OF STROKE, 2009, 4 (04) :294-299
[5]   Asymptomatic Carotid Surgery Trial-2 (ACST-2): Rationale for a Randomised Clinical Trial Comparing Carotid Endarterectomy with Carotid Artery Stenting in Patients with Asymptomatic Carotid Artery Stenosis [J].
Rudarakanchana, N. ;
Dialynas, M. ;
Halliday, A. .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2009, 38 (02) :239-242
[6]   Safety of Stenting and Endarterectomy by Symptomatic Status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) [J].
Silver, Frank L. ;
Mackey, Ariane ;
Clark, Wayne M. ;
Brooks, William ;
Timaran, Carlos H. ;
Chiu, David ;
Goldstein, Larry B. ;
Meschia, James F. ;
Ferguson, Robert D. ;
Moore, Wesley S. ;
Howard, George ;
Brott, Thomas G. .
STROKE, 2011, 42 (03) :675-680
[7]   AHA/ACCF Secondary Prevention and Risk REduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 Update - A Guideline from the American Heart Association and American College of Cardiology Foundation [J].
Smith, Sidney C., Jr. ;
Benjamin, Emelia J. ;
Bonow, Robert O. ;
Braun, Lynne T. ;
Creager, Mark A. ;
Franklin, Barry A. ;
Gibbons, Raymond J. ;
Grundy, Scott M. ;
Hiratzka, Loren F. ;
Jones, Daniel W. ;
Lloyd-Jones, Donald M. ;
Minissian, Margo ;
Mosca, Lori ;
Peterson, Eric D. ;
Sacco, Ralph L. ;
Spertus, John ;
Stein, James H. ;
Taubert, Kathryn A. .
CIRCULATION, 2011, 124 (22) :2458-2473